SANE Stock Overview
Provides various financial services worldwide. More details
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Banco Santander, S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €4.59 |
52 Week High | €4.89 |
52 Week Low | €3.58 |
Beta | 1.32 |
11 Month Change | -0.48% |
3 Month Change | 7.34% |
1 Year Change | 22.89% |
33 Year Change | 47.57% |
5 Year Change | 31.75% |
Change since IPO | 4.99% |
Recent News & Updates
Recent updates
Shareholder Returns
SANE | GB Banks | GB Market | |
---|---|---|---|
7D | 4.3% | 2.5% | -0.3% |
1Y | 22.9% | 34.7% | 6.1% |
Return vs Industry: SANE underperformed the UK Banks industry which returned 33.6% over the past year.
Return vs Market: SANE exceeded the UK Market which returned 5.6% over the past year.
Price Volatility
SANE volatility | |
---|---|
SANE Average Weekly Movement | 4.0% |
Banks Industry Average Movement | 3.8% |
Market Average Movement | 4.7% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: SANE has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: SANE's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1856 | 208,080 | Hector Grisi Checa | www.santander.com |
Banco Santander, S.A. provides various financial services worldwide. The company operates through Retail Banking, Santander Corporate & Investment Banking, Wealth Management & Insurance, and PagoNxt segments. It offers demand and time deposits, mutual funds, and current and savings accounts; mortgages, consumer finance, loans, and various financing solutions; and project finance, debt capital markets, global transaction banking, and corporate finance services.
Banco Santander, S.A. Fundamentals Summary
SANE fundamental statistics | |
---|---|
Market cap | €70.36b |
Earnings (TTM) | €11.75b |
Revenue (TTM) | €47.79b |
6.0x
P/E Ratio0.7x
P/B RatioIs SANE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SANE income statement (TTM) | |
---|---|
Revenue | €47.79b |
Cost of Revenue | €0 |
Gross Profit | €47.79b |
Other Expenses | €36.04b |
Earnings | €11.75b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
Earnings per share (EPS) | 0.77 |
Gross Margin | 100.00% |
Net Profit Margin | 24.59% |
Debt/Equity Ratio | 359.5% |
How did SANE perform over the long term?
See historical performance and comparison